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SUMMARY
Objective: To assess the distance covered by both eutrophic individuals and individuals 
with different grades of obesity and correlate the data obtained with spirometric values. 
This study is justified by the existing difficulty in assessing the functional capacity in 
obese individuals, and by the low cost and good specificity of  six-minute walk test 
(6MWT) in predicting reduced capacity for activities of daily living for any individual. 
Methods: One hundred fifty-four individuals of both genders were assessed after be-
ing divided into two groups: G1, obese individuals (n = 93, BMI ≥ 30 kg/m2) and G2, 
eutrophic individuals (n = 61, BMI 18.5 to 24.99 kg/m2). The 6MWT was performed 
using the methodology described by the American Thoracic Society (ATS-2002). 
Spirometry was performed both before and after the application of a bronchodilator 
agent (BDA) in accordance with the Guidelines for Pulmonary Function Tests by the 
Brazilian Society of Pneumology and Phthisiology (SBPT-2002). The statistical analy-
sis, consisting of mean, standard deviation, Pearson’s correlation, Student’s t test and 
Spearman’s correlation, considered p < 0.05. Results: The 6MWT analysis with spirom-
etry for G1 was positively correlated only with pre- and post-BDA peak expiratory flow 
rate (PEFR). Conclusion: The present study showed a positive correlation between pre- 
and post-BDA PEFR and the distance covered in the 6MWT in obese subjects, that is, 
the higher the PEFR, the higher the physico-functional capacity of the individual, and 
consequently, the greater the distance covered.
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INTRODUCTION
Obesity is a worldwide epidemical disease of fat accumula-
tion in the body, caused by excessive and chronic intake of 
caloric foods linked to a low energy expenditure mainly 
related to a sedentary lifestyle1-3.
Etiology and risk factors for the development of obesity 
are multiple, including genetic and psychological aspects, 
low metabolic rate, bad dietary habits, endocrine diseases, 
side effects of drugs and sedentary behavior2.
The World Health Organization (WHO)4 indicates that 
approximately 1.6 billion adults were overweight in 2005 
worldwide, and at least 400 million were obese. Projections 
for 2015 show that 2.3 billion adults will be overweight and 
over 700 million will be obese.
The second phase of the 2002-2003 Family Budget 
Survey by the Instituto Brasileiro de Geografia e Estatísti-
ca (IBGE)5 demonstrated that out of 95.5 million people 
≥ 20 years of age, 38.8 million (40.6%) were overweight, 
with 10.5 million being considered obese.
The classification of overweight and obesity in adults 
is expressed by the body mass index (BMI – kg/m2). This 
index is defined by the weight in kilograms (kg) divided 
by the squared stature in meters (m2). Individuals with 
a BMI  <  18.5  kg/m2 are underweight; between 18.5 and 
24.9  kg/m2 they are considered normal; between 25 and 
29.9  kg/m2 they are overweight. BMI classifications for 
obesity are: grade I, a BMI from 30 to 34.9 kg/m2; grade II, 
between 35 and 39.9 kg/m2; grade III or extreme obesity 
for BMI ≥ 40 kg/m2,4,6.
Five decades ago, obesity was recognized to affect 
lung function, producing mechanical effects reflected on 
the pulmonary mechanics, possibly leading to a reduced 
complacency, which may result in a restrictive ventilatory 
disorder7-10.
The simple spirometry is a pulmonary function test 
measuring the air inhaled and exhaled by the lungs and the 
following pulmonary volumes and capacities: forced vital 
capacity (FVC); forced expiratory volume in one second 
(FEV1); forced expiratory flow between 25% and 75% of 
the FVC (FEF25-75%); VEF1/FVC ratio and peak expiratory 
flow rate (PEFR)7,11.
Spirometry is indicated to detect whether a pulmo-
nary dysfunction is present or not; to rate the severity of 
a known pulmonary disease; to follow-up the pulmonary 
function under therapy and the disease course; to assess 
the effects from environmental and occupational expo-
sure; and others12.
Spirometry is a safe procedure, but increased intracra-
nial pressure, syncope, dizziness, chest pain, paroxysmal 
cough, risk for infections, bronchospasm, and pneumo-
thorax can occur12.
Grade III obesity can impair the respiratory system be-
cause of perithoracic and abdominal fat accumulation, re-
ducing the expiratory reserve volume (ERV) and the func-
tional residual capacity (FRC), also promoting ventilation/
perfusion (V/Q) ratio changes from hypoxemia rest and 
supine hypoxemia, likely because of small airway closure13.
The six-minute walk test (6MWT) is a practical and 
simple assessment of the submaximal level of functional 
exercise capacity for activities of daily living14. It mea-
sures the distance a person can walk fast on a flat and hard 
surface over six minutes. The test assesses and integrates 
responses from all systems involved during the exercise 
(cardiovascular, respiratory, neuromuscular, and meta-
bolic systems), but it does not provide specific and isolated 
information15.
The 6MWT is mainly indicated for: comparing pre- and 
post-treatment phases; measuring the functional status; 
and predicting the morbidity and mortality from cardiopul-
monary diseases. The primary measurement is the total dis-
tance covered. The secondary measurement includes mus-
cle fatigue and dyspnea, assessed by the modified Borg Scale 
or a Visual Analogue Scale. The last measurement would be 
the saturation of peripheral oxygen (SpO2), measured by a 
pulse oximeter16. Absolute contraindications are: stable and 
unstable angina, recent acute myocardial infarction; relative 
contraindications are: heart rate at rest higher than 120 bpm; 
systolic blood pressure (SBP) higher than 180 mmHg, and 
diastolic blood pressure (DBP) over 100 mmHg15.
From the literature review, no specific studies of refer-
ence values for physical-functional and pulmonary capac-
ity in obese individuals compared to eutrophic individuals 
were found. The correlation of these capacities has a consid-
erable clinical relevance, as it can contribute to setting strat-
egies for preventive treatment and complication treatment 
in obesity in order to offer better respiratory conditions with 
an appropriate choice of the therapeutic method to help in-
dividuals to be embedded into a treatment group.
The rationale for this study was the difficulty in assessing 
functional capacity in obese individuals. The 6MWT has a 
low cost, is easily applied, and its good specificity in predict-
ing reduced capacity for the activities of daily living in any 
individual has also influenced the choice.
The present study aimed to assess the influence of excess 
body weight on pulmonary and physical-functional capac-
ity, correlating variables of spirometry testing and the six-
minute walk test in different grades of obesity and in eutro-
phic individuals.
METHODS
The sample consisted of 154 sedentary volunteers of both 
genders between 20 and 59 years of age, non-smokers 
and divided into two groups: study group (G1) formed 
by 93 obese subjects (BMI ≥ 30 kg/m2) and control group 
(G2), consisting of 61 eutrophic subjects (BMI 18.5 to 
24.99 kg/m2). G2 should have a normal spirometry and 
all volunteers signed an informed consent and concluded 
the tests proposed.
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Volunteers with physical-mental changes who might 
not understand the test performance, such as in behavior 
disorders, with associated and decompensated diseases 
(heart, metabolic, pulmonary, neuromuscular, and muscu-
loskeletal diseases) significantly limiting the walk, or dis-
agreement about any procedure proposed were excluded.
The present study was approved by the Ethics 
Committee of the Universidade Católica de Brasília 
(CEP/UCB 052/2009).
Volunteers were instructed to wear comfortable 
clothes, appropriate sneakers for a walk, to use their 
medication normally and not to exercise vigorously over 
the two hours preceding the tests. An evaluation form 
containing personal data, vital signs, anthropometric 
measurements, diseases associated, dyspnea grade, life 
habits, spirometric parameters and 6MWT was designed.
Initially, volunteers were weighed on a digital scale 
(Filizola) with 100 g increments and their weight was 
noted. Stature was checked by a stadiometer (Car-
diomed) affixed to the laboratory wall. Heart rate (HR) 
and saturation of peripheral oxygen (SpO2) were collect-
ed from the pulse oxymeter (Moriya®); blood pressure 
(BP) was measured by a sphygmomanometer (Missouri) 
and a stethoscope (Littman) on the left upper limb. 
Waist circumference (WC) was measured at the mid-
point between the last costal border and the iliac crest; 
hip circumference (HC) was measured at the femur ma-
jor trochanter level, in an orthostatic position. WC and 
HC were measured by a 13 mm wide long flexible mea-
sure tape (Kapor) with one-millimeter accuracy. Waist/
hip-ratio (WHR) was calculated following the circum-
ference measurement.
The 6MWT was performed using the methodology 
specified by the American Thoracic Society (ATS-2002)15 
in a hard surface, covered, long, flat and walled corridor 
which was 30 m long; meter-by-meter marks were done 
and two cones signaled the walk turn. Parameters such 
as BP, HR, SpO2, and the modified Borg scale (it assesses 
subjectively the degree of effort, assigning a grade from 0 
to 10) were collected early and late over the walk. When 
the test was terminated, the distance covered was calcu-
lated through notes of the number of turns performed 
by the volunteer.
The volunteer was instructed to undergo the test as 
fast as possible without running for six minutes, walking 
from one cone to another during the stipulated time and 
the test could be interrupted at any time.
Every minute the investigator approached the vol-
unteer and said encouragement phrases, such as: “You 
are doing well!” and “Only a few minutes left!”. At these 
points, SpO2 and HR were verified in the oxymeter con-
nected to the volunteer through an elastic belt to avoid 
many displacements and swings and keep the safety of 
the equipment use.
As soon as the 6MWT was finished, the volunteer 
should sit down and rest for approximately 30  minutes 
to undergo the spirometry pre- and post-bronchodila-
tor agent (Spirometer: V Max 229 Sensor Medics), per-
formed by a trained technician, that is, the volunteer un-
derwent spirometry and after the bronchodilator agent 
(BDA) administration, he/she waited for 15  minutes to 
undergo a new spirometry so that the response to the 
bronchodilator agent could be evaluated.
The spirometry was performed with the volunteer 
sitting and using disposable mouthpieces for individual 
use with nose clip, in accordance with the recommen-
dations in the Guidelines for Pulmonary Function Tests 
(Brazilian Society of Pneumology and Phthisiology: 
SBPT-2002)11. Spirometry report was made by a pneu-
mologist in charge of the Cardiopulmonary Rehabilita-
tion Laboratory of Universidade Católica de Brasília.
In the statistical treatment by SPSS 17.0 data explor-
atory analyses were made to identify possible misconduct 
cases or extreme values, normality test for variables, and 
descriptive statistics with mean and standard deviation 
for age, BMI and the other pre- and post-BDA spiromet-
ric values.
Pearson coefficient of correlation was used to verify a 
possible association between BMI and the distance cov-
ered the WC, and the distance covered by the 6MWT. 
The same test was used to verify the association between 
distance covered and spirometric parameters.
Student’s t test was used to compare the spirometry 
variables among the groups for independent samples. 
This test was also used to compare HR, SpO2, respiratory 
rate (RR), BP, WC, WHR and distance covered with the 
6MWT in different groups. HR in early 6MWT was com-
pared with end HR by the paired t test.
Spearman test was used to correlate the obesity grade 
with the distance covered and the spirometry. All analy-
ses were performed with a 5% significance level adopted.
RESULTS
The study included 154 subjects, with 93 in G1 and 61 in 
G2. In the obese group, mean age was 37.6 ± 10.5 years and 
BMI was 36.73 ± 5.35 kg/m2; in the eutrophic group, mean 
age was 29.6 ± 9.0 years and BMI was 22.5 ± 2.05 kg/m2. 
In G1, 64.5% were females and 35.5% were males; in G2, 
73.8% were females and 26.2% were males. Regarding 
the obesity grade, the sample included 42 grade I obesity 
subjects (45.2%), 28 grade II obesity subjects (30.1%), 
and 23 grade III obesity subjects (24.7%).
As the groups were compared concerning WC, WHR 
and distance covered over the 6MWT measurements, sig-
nificant differences were observed for all variables across 
the groups. Obese subjects had a WC 114.7  ±  16.7  cm 
versus 75.8  ±  9.3  cm in the eutrophic group. As for 
WHR, the mean was 0.93 ± 0.07 cm for obese subjects and 
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Table 1 – Comparison between groups: HR, SpO2, RR, WC, WHR, and distance covered over the 6MWT
Variable G1 (n = 93) G2 (n = 61) t p
HR at rest (bpm) 84 ± 10.7 84 ± 13.1 -0.01 0.99
SpO2 at rest (%) 95 ± 1.7 95 ± 2.1 -0.24 0.80
RR (breaths per minute) 15 ± 3.5 16 ± 3.6 -1.81 0.07
WC (cm) 114.7 ± 16.7 75.8 ± 9.3 18.40 0.001*
WHR (cm) 0.93 ± 0.07 0.79 ± 0.07 11.60 0.001*
Distance covered over the 6MWT (m) 531.5 ± 57.2 589.0 ± 45.1 -6.60 0.001*
*p < 0.05 is significant.
HR, heart rate; SpO2, oxygen peripheral saturation; RR, respiratory frequency; WC, waist circumference; WHR, waist/hip ratio; m, meters; 
bpm, beats per minute; cm, centimeters; %, percentage.
0.79 ± 0.07 cm for eutrophic group. In the 6MWT, obese 
subjects covered a mean of 531.5 ± 57.2 m, and eutrophic 
subjects, 589 ± 45.1 m.
Regarding HR, SpO2 and RR at rest, the groups are sta-
tistically equal, with means and standard deviation shown 
in Table 1.
Pearson coefficient of correlation identified a negative 
and moderate correlation (p  =  0.001) between BMI and 
the distance covered over the 6MWT; a negative and slight 
association (p = 0.001) was demonstrated between the dis-
tance covered and WC in G1 and, in G2, there was no sig-
nificant correlation between both variables.
Analysis of HR and SpO2 evolution in both groups ev-
ery minute in the 6MWT demonstrated significant corre-
lation for HR at the third (p = 0.014), fifth (p = 0.016), and 
sixth (0.031) minutes. G1 had a lower HR than G2 all over 
the test. However, SpO2 had no difference between both 
groups.
Systolic (SBP) and diastolic (DBP) BP compared be-
tween the groups showed differences for all initial and end 
variables (p = 0.001) in 6MWT, with G1 having the highest 
variable values.
As HR was compared before and at the end of the 
6MWT in each group, a statistical significance was ob-
served (p = 0.001), with G1 showing a mean initial and end 
HR in the 6MWT 84.5 ± 10.7 bpm and 133 ± 17.4 bpm, 
respectively, lower than G2, which had a mean initial 
84.6 ± 13.1 bpm and 139.1 ± 16.8 bpm for the end-of-the 
test HR.
Before the 6MWT, the exertion perception on the 
modified Borg scale was chosen. In G1, 57 volunteers ini-
tiated the walk with no exertion (Borg 0), 11 with minimal 
exertion (Borg 0.5), 7 with very little exertion (Borg 1), 12 
with little exertion (Borg 2) and 6 with moderate exertion 
(Borg 3). In G2: 46 volunteers initiated the walk at Borg 0, 
9 at Borg  0.5, 2 at Borg  1, 3 at Borg  2, and only one at 
Borg 3.
At the end of the 6MWT, the exertion perception for 
G1 was: 2 obese subjects ended the walk at Borg  0; 6 at 
Borg  0.5; 8 at Borg  1; 24 at Borg  2; 33 at Borg  3; 8 had 
a nearly severe exertion (Borg  4); 6 had severe exertion 
(Borg 5); 4 had profound exertion (Borg 7); and 2 maxi-
mum exertion (Bort 10). In G2: 4 eutrophic subjects had 
Borg 1; 4 had Borg 0.5; 15, Borg 2; 26, Borg 3; two, Borg 4; 
seven, Borg 5; and 3 Borg 7.
As the association between obesity grade and distance 
covered over the 6MWT was verified, Spearman coefficient 
demonstrated a negative and moderate correlation between 
the variables (p = 0.001), i.e., subjects with grade I obesity 
covered a longer distance than the other obese subjects.
The spirometric parameters pre- and post-BDA FEV1/
FVC (p  =  0.0001) and post-BDA FEF25-75% (p  =  0.04) 
showed a negative correlation compared with all the spi-
rometric parameters in both groups, with G1 showing re-
duced values related to G2.
When the obesity grade was correlated with the spi-
rometry parameters by Spearman test, a negative associa-
tion of the peak expiratory flow rate was found. For pre-
BDA PEFR the p-value was 0.007, whereas for post-BDA 
PEFR p = 0.02, i.e., the higher the obesity grade, the lower 
the peak flow reached. For the other parameters, there was 
no significant correlation.
The mean spirometric parameters for pre-BDA FVC 
and post-BDA FEV1 were lower in grade II obese subjects 
related to grade III obese subjects, differing from the other 
parameters which had decreasing means as obesity in-
creased (Table 2).
The spirometry had five different spirometric reports 
for G1, with 84 revealing a normal spirometry (90.3%); 
five had a slight reversible post-BDA obstructive ventila-
tory disorder (5.4%); three had a slight restrictive venti-
latory disorder (3.2%) and only one subject had a mixed 
ventilatory disorder with a moderate nonreversible post-
BDA obstructive component (1.1%).
As the association between 6MWT and the sample 
spirometry variables was analyzed, a slight positive corre-
lation was found for pre-and post-BDA FEV1/FVC, post-
BDA FEF25-75%, pre- and post-BDA PEFR, indicating the 
longer the distance covered, the higher these spirometry 
parameters, as shown in Table 3.
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Table 2 – Mean percentage of spirometry predicted values in the obese group, according to the obesity grade (n = 93)
Spirometry
(predicted %)
Grade I (n = 42) Grade II (n = 28) Grade III (n = 23)
Pre-BDA Post-BDA Pre-BDA Post-BDA Pre-BDA Post-BDA
FVC 102.3 ± 14.6 101.1 ± 14.2 96.8 ± 12 96.6 ± 12 98.6 ± 12.2 99.5 ± 11.4
FEV1 100.8 ± 14 101 ± 13.8 95 ± 11.8 96.7 ± 12.4 94.6 ± 13 96.8 ± 13.2
FEV1/FVC 82.9 ± 3.9 84.3 ± 3.8 82.3 ± 4.3 83.5 ± 3.9 81.3 ± 6.6 82.3 ± 4.4
FEF25-75% 100 ± 21.9 107.7 ± 23.2 93.5 ± 23.2 101.6 ± 25.4 87.4 ± 24.1 94.9 ± 24.4
PEFR* 109.3 ± 17.7 107.3 ± 16.7 103.5 ± 17.1 106.9 ± 18 89.1 ± 16.3 93.5 ± 16.8
* p < 0.05 is significant.
Pre-BDA, pre-bronchodilator agent; Post-BDA, post-bronchodilator agent; FVC, forced vital capacity; FEV1, forced expiratory volume in one 
second; FEF25-75%, forced expiratory flow between 25% and 75% of the FVC; FEV1/FVC = FEV1/FVC ratio; PEFR, peak expiratory flow rate.
Table 3 – Correlation between the whole sample of the distance 
covered over 6MWT and spirometry (Pearson Coefficient)
Spirometry 6MWT (n = 154)
(predicted %) r p
Pre-BDA FVC 0.050 0.54
Post-BDA FVC -0.008 0.92
Pre-BDA FEV1 0.137 0.09
Post-BDA FEV1 0.112 0.16
Pre-BDA FEV1/FVC 0.213 0.008*
Post-BDA FEV1/FVC 0.29 0.001*
Pre-BDA FEF 25-75% 0.148 0.07
Post-BDA FEF 25-75% 0.196 0.015*
Pre-BDA PEFR 0.174 0.031*
Post-BDA PEFR 0.205 0.011*
*p < 0.05 is significant.
Pre-BDA, pre-bronchodilator agent; Post-BDA, post-bronchodilator 
agent; FVC, forced vital capacity; FEV1, forced expiratory volume 
in one second; FEF25-75%, forced expiratory flow between 25% and 
75% of the FVC; FEV1/FVC = FEV1/FVC ratio; PEFR, peak expiratory 
flow rate.
According to ATS15, the 6MWT should be discontin-
ued if the volunteer have chest pain, unbearable breath-
lessness, leg cramps, dizziness, excess sweating and pallor. 
In the study, only an eutrophic female volunteer needed to 
close the test from severe back pain.
The eutrophic females covered a mean of 
583.44  ±  43.75  m versus 522.61  ±  48.54  m for obese fe-
males, and eutrophic males obtained a mean covered dis-
tance 604.68 ± 46.47m versus 547.81 ± 68.16 m for the 
obese ones. This data bears out the study by Perecin et 
al.19, which concluded eutrophic individuals walk longer 
distances than obese individuals. In addition, they con-
firmed what ATS presents15 – two of the factors reducing 
the distance in 6MWT would be a high body weight and 
female gender. Duration of obesity, on average 10 years 
for G1, can also have contributed to the reduced distance 
covered, as complications and changes are known to arise 
over the time.
The current study shows a negative and moderate as-
sociation between the distance covered in the 6MWT 
and BMI, which was not observed by Pelegrino et al.20 in 
a study conducted with patients presenting a chronic ob-
structive pulmonary disease, with no significant associa-
tion between distance and BMI.
A slight negative association was observed when the 
obesity grade and the distance covered overt the 6MWT 
were correlated, in which the lower the obesity grade, the 
longer the distance covered. The same result was found by 
Pires et al.21 with different BMI grades.
The oxygen desaturation peak over the 6MWT, in this 
study, was maintained over the first minute for obese sub-
jects and over the first three minutes for eutrophic subjects, 
unlike the study by Brunetto et al.22 with COPD patients, 
who reached the peak at the third and sixth minutes of the 
test, demonstrating a lack of physical functional fitness in 
obese individuals.
In obesity, the function of respiratory muscles is im-
paired from the increased resistance they must overcome 
and from the reduced capacity of these muscles23. In-
creased body fat can affect pulmonary function tests, with 
a slight decrease in pulmonary volumes being associated. 
As the same analysis of 6MWT with the spirometric pa-
rameters only for G1 is performed, a weak positive correla-
tion was observed only for pre- (p = 0.007) and post-BDA 
(p = 0.005) PEFR, i.e., the longer the distance covered, the 
higher the PEFR value in the obese group, whereas for G2 
there was no significant correlation.
DISCUSSION
According to Enright and Sherril17, there are formulas pre-
dicting the distance covered over the 6MWT regarding 
age, weight and stature. In the study by Barata et al.18, the 
attempted establishment of specific formulas for Brazil-
ian healthy elderly individuals was frustrated due to small 
sample. No studies using specific reference values or for-
mulas for obese individuals were found and so predicting 
equations were not used in the current study.
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As shown by Collins et al.24, FVC, VEF1 and total pulmo-
nary capacity (TPC) are significantly decreased in patients 
with elevated body fat. This was also observed in the pres-
ent study, in which the mean predicted percentage of spi-
rometric parameters decreased as the obesity grade rose.
The present study results bear out data by Domin-
gos-Benício et al.25, who found no significant differences 
between FVC and FEV1 values in both eutrophic and 
obese subjects. However, the results contradict these au-
thors’ statement that there would be a difference in the 
FEV1/FVC ratio between both groups.
According to Teixeira et al.10, the higher the excess 
weight, the lower the FEV1/FVC ratio and FEF25-75%. There 
is a controversy in the study by Jones and Nzekwu26, which 
showed obesity is associated with a high FEV1/FVC ratio. 
The present study found a negative correlation for post-
BDA FEF25-75% between both groups, indicating this value 
is reduced in the obese group.
Obese people often complain of dyspnea, even though 
they do not have a demonstrable lung disease27. Obesity can 
cause a limited airway flow, with reduced VEF1 and FVC. 
Unlike asthma, these reductions are typically symmetrical 
and result in a preserved FEV1/FVC ratio. A number of 
authors demonstrate the FEV1/FVC ratio is increased in 
obesity, consistently with the restrictive physiology9,28.
It is noteworthy that out of 93 obese subjects, only 
three had a mild restrictive ventilatory disorder diagnosed 
by spirometry, i.e., 3.2%. In the study by Silva et al.13, over 
10% of the 50-patient-sample were found with a mild to 
moderate restriction grade, and Faintuch et al.29 diagnosed 
20.9% of mild restrictive grade in 46 candidates for bariat-
ric surgery.
Airway narrowing from obstructive phenomena asso-
ciated with weight gain could explain the other diagnoses 
in the study, as Teixeira et al.10 believed in a study of grade 
II and III obese subjects.
According to Pereira11, airway obstruction is a feature 
in asthma, emphysema, chronic bronchitis, bronchiolitis, 
and bronchiectasis. However, in the present study, no vol-
unteer had any of these diseases previously diagnosed.
The 6MWT reproducibility seems to be higher than 
that for FEV1 in patients with COPD15. A number of stud-
ies show significant associations between the distance over 
the 6MWT and FEV120,30. However, Pereira11 states FEV1 
is weakly correlated with exercise capacity and symptom 
improvement in patients with COPD.
The present study showed a positive correlation be-
tween pre- and post-BDA PEFR and the distance covered 
over the T6WT in obese subjects. PEFR is an exertion-
dependent expiratory parameter, reflecting the airway 
caliber. Therefore, when airways are narrow and have a 
reduced PEFR, the distance covered over the 6MWT will 
also be reduced, enabling a cause and consequence hy-
pothesis.
A positive correlation between the pre- and post-bron-
chodilator agent peak expiratory flow rate and the distance 
covered over the 6MWT can be found in obese individuals, 
i.e., the higher the PEFR, the higher the individual physical-
functional capacity and the longer the distance covered.
A relevant point in the study was obese group covered 
a shorter distance over the 6MWT compared with the eu-
trophic group, with a significant difference. This shows the 
interference a number of years of obesity settlement can 
cause on the individual and demonstrates the clinical im-
portance of this finding for further studies.
Another important finding was the higher the obesity 
grade, the bigger the repercussions these individuals could 
show in spirometric parameters, which were reduced in 
this group.
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